{"input_url":"https://www.nature.com/articles/s41531-026-01270-6","gnews_decode":"https://www.nature.com/articles/s41531-026-01270-6","http_status":200,"final_url":"https://www.nature.com/articles/s41531-026-01270-6","html_length":424731,"trafilatura_result":"ok","text_length":58549,"text_preview":"Abstract\nThis exploratory, single-group, open-label study investigated 17 patients with Parkinson’s disease (PD) using a pre-post design. Motor and non-motor outcomes were assessed through clinical scales, biochemical and genetic analyses, and machine learning models (Gradient Boosting Machines, Ran","verdict":"OK"}